ASX:BB1Health Care Equipment & ServicesHealth Care Technology
BlinkLab Ltd
$0.725
+$0.050 (+7.41%)
Day Range
$0.710 – $0.780
52 Week Range
$0.430 – $1.105
Volume
791.53K
Avg Volume (10D)
132.72K
Market Cap
$111.11M
Price Chart
Market Statistics
Open$0.740
Previous Close$0.675
Day High$0.780
Day Low$0.710
52 Week High$1.105
52 Week Low$0.430
Valuation
Market Cap111.11M
Shares Outstanding153.26M
Price to Book14.43
Trading Activity
Volume791.53K
Value Traded583.18K
Bid$0.720 × 3,917
Ask$0.725 × 257
Performance
1 Day0.00%
5 Day14.41%
13 Week5.47%
52 Week56.98%
YTD-16.67%
Technical Indicators
RSI (14)63.73
50-Day SMA$0.637
200-Day SMA$0.765
Latest News
Biotechnology
BlinkLab Reports Positive ADHD Assessment Results from European Dx2 Diagnostic Platform Study
BlinkLab reports ADHD Dx2 results: 82% sensitivity, 83% specificity in European study, signaling new smartphone-based diagnostic tool.
Biotechnology
BlinkLab Raises A$17.5m to Fund FDA Autism Diagnostic Clearance and Advance ADHD Trials
BlinkLab raises oversubscribed A$17.5m to push FDA autism Dx1 clearance and start ADHD Dx2 trials; Morocco rollout underpins real-world data.
Biotechnology
BlinkLab Commences Pivotal FDA 510(k) Validation Program with First Participant Enrolment
BlinkLab kicks off pivotal FDA 510(k) validation for Dx1 autism diagnostic aid; first participant enrolled as an 8-month study targeting end-2026 submission.
Biotechnology
BlinkLab Completes Pivotal FDA Study Site Network Ahead of Q1 2026 Trial Start
BlinkLab completes 10-site pivotal FDA study network ahead of March 2026 start; pilot 83.7%/84.7%; 510(k) submission H2 CY2026.